Jin Y - Search Results

1

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.

Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE Jr, Fallon JH, Kennedy JL. Potkin SG, et al. Among authors: jin y. Mol Psychiatry. 2003 Jan;8(1):109-13. doi: 10.1038/sj.mp.4001191. Mol Psychiatry. 2003. PMID: 12556915 Clinical Trial.

2

A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH. Potkin SG, et al. Among authors: jin y. Am J Psychiatry. 2002 Feb;159(2):227-37. doi: 10.1176/appi.ajp.159.2.227. Am J Psychiatry. 2002. PMID: 11823264

3

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

Potkin SG, Bera R, Gulasekaram B, Costa J, Hayes S, Jin Y, Richmond G, Carreon D, Sitanggan K, Gerber B, et al. Potkin SG, et al. Among authors: jin y. J Clin Psychiatry. 1994 Sep;55 Suppl B:133-6. J Clin Psychiatry. 1994. PMID: 7961557 Clinical Trial.

4

Clozapine effects on glucose metabolic rate in striatum and frontal cortex.

Potkin SG, Buchsbaum MS, Jin Y, Tang C, Telford J, Friedman G, Lottenberg S, Najafi A, Gulasekaram B, Costa J, et al. Potkin SG, et al. Among authors: jin y. J Clin Psychiatry. 1994 Sep;55 Suppl B:63-6. J Clin Psychiatry. 1994. PMID: 7961576 Clinical Trial.

5

Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment.

Jin Y, Potkin SG, Sandman CA, Bunney WE Jr. Jin Y, et al. Clin Electroencephalogr. 1998 Apr;29(2):73-8. doi: 10.1177/155005949802900205. Clin Electroencephalogr. 1998. PMID: 9571294 Clinical Trial.

6

Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.

Potkin SG, Jin Y, Bunney BG, Costa J, Gulasekaram B. Potkin SG, et al. Among authors: jin y. Am J Psychiatry. 1999 Jan;156(1):145-7. doi: 10.1176/ajp.156.1.145. Am J Psychiatry. 1999. PMID: 9892314 Clinical Trial.

7

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics.

Potkin SG, Fleming K, Jin Y, Gulasekaram B. Potkin SG, et al. Among authors: jin y. J Clin Psychopharmacol. 2001 Oct;21(5):479-83. doi: 10.1097/00004714-200110000-00004. J Clin Psychopharmacol. 2001. PMID: 11593072 Clinical Trial.

8

Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.

Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, Carreon D, Bunney WE Jr. Jin Y, et al. Schizophr Bull. 2006 Jul;32(3):556-61. doi: 10.1093/schbul/sbj020. Epub 2005 Oct 27. Schizophr Bull. 2006. PMID: 16254067 Free PMC article.

9

P50 sensory gating ratios in schizophrenics and controls: a review and data analysis.

Patterson JV, Hetrick WP, Boutros NN, Jin Y, Sandman C, Stern H, Potkin S, Bunney WE Jr. Patterson JV, et al. Among authors: jin y. Psychiatry Res. 2008 Mar 15;158(2):226-47. doi: 10.1016/j.psychres.2007.02.009. Epub 2008 Jan 9. Psychiatry Res. 2008. PMID: 18187207 Review.

10

Clozapine increases EEG photic driving in clinical responders.

Jin Y, Potkin SG, Sandman C. Jin Y, et al. Schizophr Bull. 1995;21(2):263-8. doi: 10.1093/schbul/21.2.263. Schizophr Bull. 1995. PMID: 7631173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,488 results

Search Page

Filters